StarsInsider on MSN2d
Rett syndrome: the genetic disorder predominantly affecting girlsIf you haven't heard of Rett syndrome, it's probably because it's very rare. Affecting an estimated one in 12,000 baby girls ...
Discover WildScience on MSN4d
The Work of Dr Huda Zoghbi in Neuroscience Discovering the Genetic Cause of Rett SyndromeThe field of neuroscience has benefited significantly from the groundbreaking work of dedicated researchers who have ...
Phil and Claire Drinkwater have raised more than £11,000 for charity since the loss of their 'joyful' son Jude ...
2d
Stockhead on MSNRare opportunities – ASX health stocks tackling unmet medical needsRare diseases have become an attractive target for pharmaceutical companies both in Australia and internationally with ...
1d
Stockhead on MSNNeurotech inks European development deal for cannabinoid therapiesSpecial Report: Neurotech International has inked a deal with a European leader in development and scale up of cannabis-based ...
Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage ...
Romi Loffler fears she will be among the hardest hit by East Renfrewshire Council's decision to means-test and charge for ...
Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmac ...
Acadia Pharmaceuticals' forecasted revenues top $1bn in 2025. Find out why ACAD stock is a "Buy" with its profitable outlook ...
Kennesaw State biochemistry student unlocks passion for research through First-Year Scholars program
It didn’t take long for Kennesaw State University student Lilianna Kocai to discover a passion for research. All it took was a little nudge from assistant professor Carl Saint-Louis. As a freshman in ...
Bishop asked about upcoming events. Missling outlined the anticipated schizophrenia trial readout for ANAVEX 3-71 in the first half of 2025, the detailed ATTENTION-AD data presentation in April, and ...
Good morning, everyone, and welcome to the Anavex Life Sciences Fiscal 2025 First Quarter Conference Call. My name is Clint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results